Nursing care
Insulin Types: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Insulin type determines when a patient is at risk of hypoglycaemia, because onset, peak and duration differ across rapid-acting (lispro, aspart), short-acting (regular), intermediate (NPH) and long-acting (glargine, detemir) forms. Rapid-acting insulin must be given with food already in front of the patient; long-acting insulin has no peak and is never mixed with other insulins.
What it does and why it is prescribed
Insulin replaces or supplements the hormone that moves glucose out of the bloodstream and into cells. It is prescribed in type 1 diabetes because the pancreas produces none, and in type 2 diabetes when oral agents and lifestyle measures no longer hold blood glucose in range. It is also used for gestational diabetes, diabetic ketoacidosis, hyperkalaemia management, and for any patient whose glucose is uncontrolled during acute illness or surgery.
The type of insulin ordered is a clinical decision, not an interchangeable formulary choice. Rapid-acting analogues cover a meal. Long-acting analogues cover the body's background glucose needs across the whole day. A patient on a basal-bolus regimen is usually on one of each, and mixing them up, or giving one at the wrong time relative to food, is one of the most common medication errors on a medical ward.
Nursing considerations before giving it
Check the blood glucose result before you draw up the dose, not after. Confirm the insulin type against the prescription, the pen or vial label, and the sliding scale or fixed-dose chart, since insulin errors are consistently among the highest-harm medication events reported. Two nurses should independently check high-alert insulin doses where your unit policy requires it.
Match the injection to the food. Rapid-acting insulin (lispro, aspart, glulisine) has an onset of ten to twenty minutes, so it is given immediately before or with the meal, never earlier, and only if the patient is able and ready to eat. Regular insulin has a slower thirty-minute onset and is given further ahead of the meal. NPH and long-acting insulins are not tied to a meal at all. Rotate injection sites within the same body region to reduce lipohypertrophy, which itself causes erratic absorption.
What to monitor
Monitor blood glucose before administration and again at the time each insulin type is expected to peak, since that is when hypoglycaemia will show up. Rapid-acting insulin peaks at roughly one to three hours after injection. Regular insulin peaks at two to five hours. NPH peaks at four to twelve hours, which is why a bedtime NPH dose can cause a two a.m. hypoglycaemic episode that a daytime check will never catch. Long-acting insulins such as glargine and detemir are designed to have no pronounced peak, giving a flatter, steadier profile over roughly twenty-four hours.
Duration of action tells you how long that risk window stays open. Rapid-acting insulin is out of the system in three to five hours; NPH can still be active at eighteen hours; glargine is still working at twenty-four. Track trends across shifts, not single readings, and correlate any low result with the specific insulin and the time it was given, because that is what identifies which product is responsible.
Side effects versus adverse effects
Expected side effects are localised: mild injection-site redness, stinging, or small areas of lipohypertrophy from repeated injections in the same spot. These are managed with site rotation and patient reassurance and do not require the dose to be held.
Adverse effects are systemic and dose-related, and the defining one is hypoglycaemia, which follows directly from the onset, peak and duration profile of whichever insulin was given. Severe hypoglycaemia can progress to confusion, seizure, or loss of consciousness and needs immediate treatment. Rarer adverse effects include lipoatrophy, systemic allergic reaction to the insulin protein itself, and hypokalaemia, since insulin drives potassium into cells alongside glucose.
What to hold for and when to call
Hold a scheduled insulin dose if the blood glucose result is below the threshold set in your facility's protocol, commonly around 4 mmol/L or 70 mg/dL, and treat the low first. Hold or delay a mealtime rapid-acting dose if the patient is not going to eat, is nil by mouth, or has ongoing nausea and vomiting, since giving it anyway is a direct cause of iatrogenic hypoglycaemia.
Call the prescriber for any unexplained low reading that does not fit the expected peak time, for recurrent hypoglycaemia, for glucose that stays high despite correction doses, or for any sign of allergic reaction. Escalate immediately for confusion, seizure, or an unresponsive patient, treat per your hypoglycaemia protocol, and document the insulin type and the exact time it was given so the pattern can be reviewed.
Patient teaching
Teach the patient which insulin they are on by name and by role, not just as one generic drug. They need to know that a rapid-acting pen is timed to the meal in front of them, that a long-acting dose is usually once daily regardless of food, and that the two are never interchangeable even in an emergency. Reinforce injection site rotation and correct storage, since insulin in use can sit at room temperature but reserve stock needs refrigeration.
Teach recognition of hypoglycaemia symptoms, sweating, shaking, confusion, hunger, and the rule of fast-acting carbohydrate followed by a recheck in fifteen minutes. Make sure the patient can state what time their insulin peaks, because that is when they are most likely to feel a low coming on, and encourage them to carry a fast-acting glucose source and medical identification at all times.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our endocrine practice questions are the closest set to what this page covers.
Common questions
What is the onset, peak and duration of lispro insulin?
Lispro has an onset of ten to fifteen minutes, peaks at roughly one to two hours, and lasts about three to five hours. It must be given immediately before or with a meal because it acts too fast to give well ahead of eating.
Does glargine have a peak?
No. Glargine is designed to release steadily over about twenty-four hours with no pronounced peak, which is why it covers background glucose needs and is dosed once daily, usually at the same time each day.
Why is NPH insulin cloudy and does it need mixing?
NPH is a suspension, not a solution, so it appears cloudy and must be gently rolled between the palms to resuspend it evenly before drawing up the dose. Shaking vigorously introduces air bubbles and can affect dose accuracy.
Can rapid-acting and long-acting insulin be mixed in the same syringe?
Regular insulin can be mixed with NPH, but insulin analogues such as glargine and detemir must never be mixed with any other insulin in the same syringe, as it alters their release profile. Draw up and inject them separately.
Why does NCLEX focus so heavily on insulin onset and peak times?
Because that timing predicts exactly when a patient is at risk of hypoglycaemia. Exam questions test whether you know to check glucose around the peak of the specific insulin given, not just at a fixed time of day.